UK markets close in 5 hours 12 minutes

DBV Technologies S.A. (DBVT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.3900-0.1600 (-6.27%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.5500
Open2.3500
Bid1.7200 x 1100
Ask2.9600 x 1200
Day's range2.3300 - 2.4500
52-week range1.1500 - 5.9900
Volume154,434
Avg. volume777,562
Market cap448.577M
Beta (5Y monthly)2.08
PE ratio (TTM)N/A
EPS (TTM)-0.7745
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.50
  • Globe Newswire

    DBV Technologies to Participate in Upcoming EAACI 2022 Congress

    Montrouge, France, June 28, 2022 DBV Technologies to Participate in Upcoming EAACI 2022 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participation at the hybrid in-person and virtual European Academy of Allergy and Clinical Immunology (EAACI) Annual Scientific meeting, July 1 – 3, 2022, in Prague, Czech Republic. Two scientific presentations have been accepted, including one non-cl

  • Globe Newswire

    DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York

    Montrouge, France, June 16, 2022 DBV Technologies to Present at the JMP Securities Life Sciences Conference in New York DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, and Dr. Pharis Mohideen, Chief Medical Officer, will participate in a fireside chat on Thursday, June 16, 2022, at 12:00 p.m. ET at the JMP Securities Life Sciences Conference in New York. A we

  • Globe Newswire

    DBV Technologies Announces Private Placement Financing of $194 Million

    Montrouge, France, June 9, 2022 DBV Technologies Announces Private Placement Financing of $194 Million DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Global Select Market: DBVT), a clinical-stage biopharmaceutical company, today announced an aggregate $194 million private investment in public equity (PIPE) financing (corresponding to €181 million on the basis of an exchange rate of $1.0739 = €1.00 published by the European Central Bank on June 8, 2022) from the sale of 32,855,669